cyclosporine has been researched along with Cancer, Radiation-Induced in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bavinck, JN; Bodmann, CA; de Gruijl, FR; Geissler, EK; Koehl, GE; Tensen, CP; Voskamp, P; Willemze, R | 1 |
Djerbi, N; Dotto, GP; Dziunycz, PJ; Freiberger, SN; French, LE; Hofbauer, GFL; Iotzowa-Weiss, G; Lefort, K; Neu, J; Wu, X | 1 |
Weiss, JM | 1 |
Oberyszyn, TM; Schick, JS; Thomas-Ahner, JM; Wulff, BC | 1 |
Behnke, W; Dasenbrock, C; Ernst, H; Hagemann, G; Kaever, V; Kellner, R; Kohler, M; Mohr, U; Rittinghausen, S; Tillmann, T; Tomatis, L | 1 |
Allen, SD; Duncan, FJ; Ferketich, AK; Kusewitt, DF; Martin, J; Oberyszyn, TM; Thomas-Ahner, JM; Tober, KL; Vanbuskirk, AM; Wulff, BC | 1 |
Duncan, FJ; Kusewitt, DF; Oberyszyn, TM; Thomas-Ahner, JM; VanBuskirk, AM; Wulff, BC | 1 |
Louahed, J; Renauld, JC; Van Snick, J; Vink, A | 1 |
Bergfelt, L | 1 |
Amenábar, JJ; Gaínza, FJ; Gómez-Ullate, P; Lampreabe, I; Urbizu, JM; Zárraga, S | 1 |
1 review(s) available for cyclosporine and Cancer, Radiation-Induced
Article | Year |
---|---|
[Presentation of cancers in recipients of a solid-organ transplant].
Topics: Carcinogens; Cell Transformation, Neoplastic; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Melanoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Postoperative Complications; Prevalence; Recurrence; Risk; Sarcoma, Kaposi; Skin Neoplasms; Transplantation; Tumor Virus Infections; Ultraviolet Rays | 2001 |
9 other study(ies) available for cyclosporine and Cancer, Radiation-Induced
Article | Year |
---|---|
No acceleration of UV-induced skin carcinogenesis from evenly spread dietary intake of cyclosporine in contrast to oral bolus dosages.
Topics: Administration, Oral; Animals; Carcinogenesis; Cyclosporine; Dose-Response Relationship, Drug; Immunosuppressive Agents; Mice; Mice, Hairless; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Skin Neoplasms; Ultraviolet Rays | 2013 |
The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A.
Topics: Activating Transcription Factor 3; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratinocytes; Neoplasms, Radiation-Induced; NF-E2-Related Factor 2; Organ Culture Techniques; Organ Transplantation; Primary Cell Culture; Reactive Oxygen Species; Skin; Skin Neoplasms; Tumor Cells, Cultured; Ultraviolet Rays | 2014 |
[Journal-Club].
Topics: Activating Transcription Factor 3; Animals; Carcinoma, Squamous Cell; Cyclosporine; Female; Human papillomavirus 16; Human papillomavirus 18; Human papillomavirus 6; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-23; Keratinocytes; Male; Neoplasms, Radiation-Induced; Nociceptors; Papillomavirus E7 Proteins; Papillomavirus Infections; Psoriasis; Sensory Receptor Cells; Skin; Skin Neoplasms; Ultraviolet Rays | 2014 |
Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.
Topics: Animals; Blotting, Western; Caspase 3; Celecoxib; Cyclooxygenase Inhibitors; Cyclosporine; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Female; Immunohistochemistry; Immunosuppressive Agents; Mice; Neoplasms, Radiation-Induced; Pyrazoles; Sirolimus; Skin Neoplasms; Sulfonamides; Tumor Suppressor Protein p53; Ultraviolet Rays | 2010 |
Maternal effects and cancer risk in the progeny of mice exposed to X-rays before conception.
Topics: Animals; Carcinogens; Cocarcinogenesis; Cyclosporine; Disease Models, Animal; Female; Fertility; Immunocompromised Host; Immunologic Factors; Longevity; Male; Maternal Exposure; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Ovum; Pregnancy; Prenatal Exposure Delayed Effects; Risk; X-Rays | 2005 |
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.
Topics: Animals; Blood Vessels; Carcinoma, Squamous Cell; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Immunosuppressive Agents; Inflammation; Mice; Mice, Hairless; Mycophenolic Acid; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Sirolimus; Skin Neoplasms; Tacrolimus; Ultraviolet Rays | 2007 |
Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.
Topics: Animals; Antineoplastic Agents; Cell Count; Cyclosporine; Disease Progression; Female; Immunosuppressive Agents; Incidence; Lymph Nodes; Mast Cells; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neutrophils; Sirolimus; Skin; Skin Neoplasms; Transforming Growth Factor beta1; Tumor Burden; Ultraviolet Rays | 2008 |
Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas.
Topics: Alkaloids; Animals; Apoptosis; Cell Division; Cyclosporine; Dexamethasone; DNA Damage; DNA, Neoplasm; Interleukin-2; Interleukin-4; Interleukin-7; Interleukin-9; Lymphoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasms, Radiation-Induced; Protein Kinase C; Signal Transduction; Staurosporine; Thymus Neoplasms; Tumor Cells, Cultured | 1995 |
Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Topics: Adenosine Triphosphatases; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Animals; Antigens, CD; Azathioprine; Carcinoma, Basal Cell; Cell Adhesion Molecules; Cell Line, Transformed; Cell Movement; Cyclosporine; Female; HLA-DR Antigens; Humans; Immune Tolerance; Intercellular Adhesion Molecule-1; Langerhans Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Nude; Middle Aged; Monitoring, Immunologic; Neoplasm Transplantation; Neoplasms, Radiation-Induced; Prednisolone; PUVA Therapy; Skin; Skin Neoplasms; T-Lymphocytes; Ultraviolet Rays | 1993 |